Supported by

Mitral valve replacement and repair

Latest mitral valve replacement and repair content in interventional cardiology - research, practice, and education

Building on the years of experience with TAVI, mitral valve replacement and repair (TMVR) is now beginning to take-off with a vast array of new techniques and options. Certain devices, for instance in mitral repair, are now widely used. To understand this complex field a knowledge and mastery is required covering the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Mitral valve replacement and repair

599 results

Rapid-fire clinical cases: Session 4

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...

Rapid-fire clinical cases: Session 4

Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn how to perform a mitral transcatheter edge-to-edge repair procedure from start to finish, to learn more about currently available devices and which one to use in specific patients, and to understand how optimal procedural imaging and device steering determine the best...

Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

Rapid-fire abstracts: Session 7

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...

Rapid-fire abstracts: Session 7

A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring

28 Nov 2022 – From PCR London Valves 2022

Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.

A case-based tailored

Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: Primary MR repair (recorded case)
    An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE.
  • Part 2: Tricuspid valve in valve (Live case)
    A 52-year-old female, with diabetes and...
Transcatheter intervention for mitral and tricuspid valve disease: state of the art

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn about the latest news in the field of mitral valve intervention and get insights into its current slow progress, which may be caused by clinical, anatomical or technological factors.

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

Secondary mitral regurgitation: challenges in management

28 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.

Secondary mitral regurgitation: challenges in management

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

28 Nov 2022 – From PCR London Valves 2022

Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

Mitral - Late-Breaking Trials and Innovations

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!

Mitral - Late-Breaking